Arkolith/Insider Trading/ALXN/Form 4

Hantson Ludwig

CEO, DirectorALEXION PHARMACEUTICALS, INC. (ALXN) · full profile →Form 4 · filed Jul 23, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 21, 2021Disposed to issuer(D)581K—$09K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 21, 2021Disposed to issuer(D)57K$118.83$6.7M0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899866-21-000063) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML